Insulet Corp. said it plans to offer $660 million worth of convertible senior notes due 2026 in a private placement.
Acton, Mass.-based Insulet may also issue up to an additional $100 million worth of notes if there is an increase in demand for the securities.
The company plans to use the private offering to refinance its existing debt, including 1.25% convertible senior notes due 2021. The debt offering will be priced later.
Insulet develops, manufactures and sells insulin delivery systems for people with insulin-dependent diabetes.
